Danone Shares Slip to €62.28, Entering Oversold Territory
Danone shares fell by 1.58% to €62.28 in mid-morning trading, against a backdrop of a 0.81% decline in the CAC 40. The stock is among the top five declines in the Paris index. This drop brings the weekly underperformance to 6.68%.
The price is currently below the lower Bollinger Band threshold, set at €63.95, indicating an oversold condition. The RSI at 32 reinforces this view following the week's drop. The previous support at €63.28 was breached during the session, and the stock is now distancing itself from its moving averages: the MM50 at €68.79 and the MM200 at €72.78 are well above the current price. The medium-term trend remains negative, with a decline of 9.95% over three months and 16.96% over a year. As a reminder, at the end of April, the stock had already erased its post-results gains by retesting its support at the time of €66.42.
Focus on the Semi-Annual Accounts on July 29
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
The financial calendar does not foresee any imminent publications: the next official event is the announcement of the first half of 2026 results, scheduled for July 29. In the meantime, the market is still digesting the first quarter revenue report released on April 22, which showed a 2.7% organic growth and revenues of €6,708 million, affected by a negative currency impact of 5.6%. Today's session occurs in a gloomy market context in Europe, with the DAX down 0.45% and the FTSE 100 dropping 1.13%. The negative beta of the stock (-0.11) does not hold true today, as Danone falls alongside the Paris index. The next financial milestone remains set for July 29.
SectorAgroalimentaire · Grande consommation›Produits alimentaires
Context
Period
Period: 1T2026
Key reported figures
Revenue: 6708M€
Guidance from the release
La performance du premier trimestre confirme, une nouvelle fois, la résilience, la solidité et la pertinence de notre portefeuille axé sur la santé.
Chiffre d'affaires en baisse de -2,0% en données publiées, mais croissance solide de +2,7% en données comparables.
Risks mentioned
Impact des rappels de laits infantiles en Europe sur la Nutrition Spécialisée.
Conflit au Moyen-Orient influençant la performance en EMEA.
Dépréciation de plusieurs devises par rapport à l'euro.
Opportunities identified
Acquisition de Huel renforçant notre présence dans la nutrition fonctionnelle.
Création d'une joint-venture avec Arcor ouvrant des opportunités dans les produits laitiers.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
